NCT06177704View on ClinicalTrials.gov

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions

Percutaneous Left Atrial Appendage Occlusion (LAAO)Device-related Thrombus (DRT)Thromboembolic EventMajor Cardioembolic EventsMajor Bleeding - TIMI Classification

Trial Locations (1)

G1V 4G5

IUCPQ-UL, Québec

All Listed Sponsors

lead

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

OTHER

NCT06177704 - Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study | Biotech Hunter | Biotech Hunter